SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-030737
Filing Date
2021-05-06
Accepted
2021-05-06 19:20:19
Documents
1
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5559
  Complete submission text file 0001209191-21-030737.txt   7045
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 SIDNEY STREET, 2ND FLOOR CAMBRIDGE MA 02139
Business Address
Bowden Christopher (Reporting) CIK: 0001608601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 21899685